Cargando…
Correction: Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578972/ http://dx.doi.org/10.1136/jitc-2020-001391corr1 |
Ejemplares similares
-
Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer
por: Chen, Peixin, et al.
Publicado: (2020) -
Galectin Expression Profiling Identifies Galectin-1 and Galectin-9Δ5 as Prognostic Factors in Stage I/II Non-Small Cell Lung Cancer
por: Schulkens, Iris A., et al.
Publicado: (2014) -
Correction: A Crucial Role for Kupffer Cell-Derived Galectin-9 in Regulation of T Cell Immunity in Hepatitis C Infection
por: Mengshol, John A., et al.
Publicado: (2010) -
Macrophages-based immune-related risk score model for relapse prediction in stage I–III non-small cell lung cancer assessed by multiplex immunofluorescence
por: Wu, Xiang-Rong, et al.
Publicado: (2022) -
Correction to: Galectin-9 promotes a suppressive microenvironment in human cancer by enhancing STING degradation
por: Zhang, Chuan-xia, et al.
Publicado: (2022)